You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 1
  • LSO-028 Predictors of de novo renal flares in systemic lupus erythematosus – time to revisit belimumab dose for extra-renal disease? Results from five phase III clinical trials of belimumab

Article metrics

Article menu

Download PDFPDF

Short Oral Presentation
Short oral presentation session 5: lupus nephritis
LSO-028 Predictors of de novo renal flares in systemic lupus erythematosus – time to revisit belimumab dose for extra-renal disease? Results from five phase III clinical trials of belimumab

 

Online download statistics by month:

Online download statistics by month: August 2023 to September 2024

AbstractFullPdf
Aug 20234506
Sep 202321011
Oct 20231402
Nov 20231202
Dec 20231602
Jan 20245401
Feb 20243403
Mar 202439023
Apr 20243603
May 20242201
Jun 20243603
Jul 20242406
Aug 20241203
Sep 20241000
Total375066